DSS Insider Filing Clarifies Ownership and $500K Convertible Note
Rhea-AI Filing Summary
DSS, Inc. amended a Form 4 to clarify insider transactions and disclose that on August 20, 2025 the company issued a $500,000 convertible promissory note to Alset Inc. The note allows Alset Inc. to convert principal and accrued interest into common stock at a conversion price of $0.86 per share, or to exchange into any subsequently issued convertible instrument on different terms based on the note balance plus accrued interest. The filing details the beneficial ownership attributable to reporting person Heng Fai Ambrose Chan, including shares held directly and through affiliated entities totaling disclosed positions across Heng Fai Holdings Limited, Alset Inc., Alset International Limited and Global Biomedical Pte. Ltd., and notes the convertible note is exercisable through July 31, 2028.
Positive
- None.
Negative
- None.
Insights
TL;DR: Amended Form 4 improves disclosure of insider holdings and a $500k convertible financing, revealing potential dilution.
The amendment clarifies the structure of insider holdings and discloses a related-party financing via Alset Inc. Clear attribution of shares held directly and indirectly by Mr. Chan enhances transparency for shareholders assessing control and voting influence. The convertible note's conversion terms and election feature to exchange into later convertible instruments add complexity to future capitalization. This is routine but material for governance and control analysis.
TL;DR: The $500,000 convertible note provides short-term funding but introduces dilution risk depending on conversion mechanics and future financings.
The disclosed conversion price of $0.86 per share establishes a potential dilution floor; if converted in full, the note would convert into a quantifiable number of shares that should be accounted for in diluted share calculations. The holder's right to exchange into later convertible instruments could alter economics for existing shareholders depending on terms of any subsequent financings. Investors should note the convertible maturity through July 31, 2028 and the aggregation of insider-controlled holdings reported.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Other | Convertible Promissory Note | 0 | $0.00 | -- |
Footnotes (1)
- This Amended Form 4 is being filed to clarify certain information set forth on the Form 4 originally filed by the reporting persons on August 22, 2025. On August 20, 2025, the Issuer issued a convertible promissory note (the "Convertible Promissory Note") to Alset Inc. in the amount of $500,000. Under the terms of the Convertible Promissory Note, Alset Inc. may convert outstanding principal and interest into shares of the Issuer's common stock at a conversion price of either (i) $0.86 per share, or (ii) if while the Convertible Promissory Note is outstanding, the Issuer sells or issues any other convertible instruments on terms that differ from the Convertible Promissory Note, the Holder may elect to exchange the Convertible Promissory Note for such convertible instrument based on the Convertible Promissory Note's principal balance plus any accrued but unpaid interest. The beneficial ownership of Mr. Chan as of August 22, 2025 may be deemed to include the following (a) 1,002,978 shares of the Issuer's common stock held by Heng Fai Holdings Limited, an entity controlled by Heng Fai Chan; (b) 1,184,475 shares of the Issuer's common stock held by Mr. Chan directly; (c) 2,581,268 shares of the Issuer's common stock held by Alset Inc., an entity controlled by Mr. Chan; (d) a convertible promissory note in the amount of $500,000 held by Alset Inc. and convertible into shares of the Issuer's common stock; (e) 1,068,309 shares of the Issuer's common stock held by Alset International Limited, an entity controlled by Mr. Chan and a subsidiary of Alset Inc.; and (f) 311,634 shares of the Issuer's common stock held by Global Biomedical Pte. Ltd., an entity controlled by Mr. Chan and a subsidiary of Alset International Limited (which is a subsidiary of Alset Inc.).
